Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tomoo Iwakuma

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
Cancers|January 21, 2023
Drugs Targeting p53 Mutations with FDA Approval and in Clinical TrialsShigeto Nishikawa, Tomoo Iwakuma
International Journal of Molecular Sciences|December 24, 2021
Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family MembersAtsushi Kaida, Tomoo Iwakuma
Molecular Cancer Research : MCR|January 7, 2004
MDM2, an introductionTomoo Iwakuma, Guillermina Lozano
Cancers|December 23, 2018
Regulators of Oncogenic Mutant TP53 Gain of FunctionSatomi Yamamoto, Tomoo Iwakuma
Cancer Research|June 17, 2020
TAp63-miRNA-AURKA Axis as a Therapeutic Target for Cutaneous Squamous Cell CarcinomaAlejandro Parrales, Tomoo Iwakuma
International Journal of Molecular Sciences|December 13, 2016
Non-Canonical Cell Death Induced by p53Atul Ranjan, Tomoo Iwakuma
Frontiers in Oncology|January 7, 2016
Targeting Oncogenic Mutant p53 for Cancer TherapyAlejandro Parrales, Tomoo Iwakuma
Cancer Metastasis Reviews|June 12, 2012
MDM2 binding protein, a novel metastasis suppressorTomoo Iwakuma, Neeraj Agarwal
International Journal of Molecular Sciences|March 31, 2018
Emerging Non-Canonical Functions and Regulation of p53Atul Ranjan, Tomoo Iwakuma
International Journal of Molecular Sciences|December 16, 2016
p53 as a Regulator of Lipid Metabolism in CancerAlejandro Parrales, Tomoo Iwakuma
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
Cancers|January 21, 2023
Drugs Targeting p53 Mutations with FDA Approval and in Clinical TrialsShigeto Nishikawa, Tomoo Iwakuma
International Journal of Molecular Sciences|December 24, 2021
Regulation of p53 and Cancer Signaling by Heat Shock Protein 40/J-Domain Protein Family MembersAtsushi Kaida, Tomoo Iwakuma
Molecular Cancer Research : MCR|January 7, 2004
MDM2, an introductionTomoo Iwakuma, Guillermina Lozano
Cancers|December 23, 2018
Regulators of Oncogenic Mutant TP53 Gain of FunctionSatomi Yamamoto, Tomoo Iwakuma
Cancer Research|June 17, 2020
TAp63-miRNA-AURKA Axis as a Therapeutic Target for Cutaneous Squamous Cell CarcinomaAlejandro Parrales, Tomoo Iwakuma
International Journal of Molecular Sciences|December 13, 2016
Non-Canonical Cell Death Induced by p53Atul Ranjan, Tomoo Iwakuma
Frontiers in Oncology|January 7, 2016
Targeting Oncogenic Mutant p53 for Cancer TherapyAlejandro Parrales, Tomoo Iwakuma
Cancer Metastasis Reviews|June 12, 2012
MDM2 binding protein, a novel metastasis suppressorTomoo Iwakuma, Neeraj Agarwal
International Journal of Molecular Sciences|March 31, 2018
Emerging Non-Canonical Functions and Regulation of p53Atul Ranjan, Tomoo Iwakuma
International Journal of Molecular Sciences|December 16, 2016
p53 as a Regulator of Lipid Metabolism in CancerAlejandro Parrales, Tomoo Iwakuma
Pageof 7